Literature DB >> 508676

Association of juvenile disciform maculopathy with HLA B15.

A Craandijk, G M Schreuder.   

Abstract

Twenty patients with juvenile disciform maculopathy (JDM), which clinically cannot be differentiated from presumed ocular histoplasmosis, are presented. Histocompatibility antigen typing showed an increase in HLA B15, but this increase was not significant with respect to the corrected P-value. We are reporting our results in the hope of encouraging those who have cases of JDM in Europe to consider histocompatibility antigens and in particular HLA B15.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508676      PMCID: PMC1043590          DOI: 10.1136/bjo.63.10.678

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  [Diagnosis and treatment of macular lesions in multifocal chorioiditis (presumed histoplasmosis) (author's transl)].

Authors:  J G Notting; A F Deutman; P J van der Werf
Journal:  Klin Monbl Augenheilkd       Date:  1975-05       Impact factor: 0.700

3.  The geographic localization of presumed histoplasmic choroiditis.

Authors:  F D Ellis; T F Schlaegel
Journal:  Am J Ophthalmol       Date:  1973-06       Impact factor: 5.258

4.  Association of presumed ocular histoplasmosis with HLA-B7.

Authors:  W A Godfrey; R Sabates; D E Cross
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

5.  Ocular histoplasmosis syndrome in the United Kingdom.

Authors:  R A Braunstein; D A Rosen; A C Bird
Journal:  Br J Ophthalmol       Date:  1974-11       Impact factor: 4.638

6.  Haemorrhagic maculopathy in young adults.

Authors:  T Flage; A B Sand; P Syrdalen
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-06

7.  The prevalence of HLA-B7 in presumed ocular histoplasmosis.

Authors:  R E Braley; T A Meredith; T M Aaberg; S M Koethe; J A Witkowski
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.